BioRestorative Therapies (BRTX) Common Equity (2010 - 2026)
BioRestorative Therapies (BRTX) recorded Common Equity of $3.03 million in Q1 2026, down 50.8% from $6.14 million a year earlier but up 748.1% from the prior quarter.
Powered by 
Analysis
BioRestorative Therapies (BRTX) Common Equity (2010 - 2026) Analysis & Trends
At the end of FY2025, BioRestorative Therapies reported Common Equity of $356,744, down 95.8% from FY2024.
- Annual Common Equity has declined for four straight years.
- Across earlier years, Common Equity came in at $8.53 million in FY2024 (-14.7%), $10 million in FY2023 (-2.8%), $10.29 million in FY2022 (-4.6%) and $10.78 million in FY2021.
- Quarterly Common Equity has ranged from -$4.88 million in Q3 2021 to $14.5 million in Q1 2024 over the past five years.
- On a year-over-year basis, Common Equity has declined for seven consecutive quarters, with an average decline of 6.4% over the last eight quarters.
- Peak year-over-year performance for Common Equity in the last five years was growth of 308.3% in Q2 2024, against a decline of 95.8% in Q4 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $356,744 (Q4 2025), $2.21 million (Q3 2025) and $4.85 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 40.27 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 81.53 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -4.58 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 44.95 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 51.81 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 14.35 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 13.04 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 89.30 Bn |
| 10 | BioRestorative Therapies | 1.36 Mn | -17.06 Mn | 15,785.00 | 3.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 3.03 Mn |
| Dec 31, 2025 | 356,744.00 |
| Sep 30, 2025 | 2.21 Mn |
| Jun 30, 2025 | 4.85 Mn |
| Mar 31, 2025 | 6.14 Mn |
| Dec 31, 2024 | 8.53 Mn |
| Sep 30, 2024 | 9.99 Mn |
| Jun 30, 2024 | 10.80 Mn |
| Mar 31, 2024 | 14.50 Mn |
| Dec 31, 2023 | 10.00 Mn |
| Sep 30, 2023 | 10.76 Mn |
| Jun 30, 2023 | 2.64 Mn |
| Mar 31, 2023 | 6.46 Mn |
| Dec 31, 2022 | 10.29 Mn |
| Sep 30, 2022 | 9.78 Mn |
| Jun 30, 2022 | 12.16 Mn |
| Mar 31, 2022 | 5.95 Mn |
| Dec 31, 2021 | 10.78 Mn |
| Sep 30, 2021 | -4.88 Mn |
| Jun 30, 2021 | -3.81 Mn |
API Access
BioRestorative Therapies Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=BRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "BRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=BRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();